Answers are grounded in this paper and cite their sources.
Multicentre European study reveals HDV-RNA predicts risk in chronic hepatitis D patients before cirrhosis, suggesting early intervention is crucial.
Baseline quantitative HDV-RNA allows early risk stratification in untreated patients with chronic hepatitis D before the development of liver cirrhosis. Once cirrhosis is established, clinical outcomes are largely independent of viral replication, emphasising the need to prioritise timely antiviral intervention and close surveillance at earlier disease stages.
No takes yet. Share an insight, caveat, or question.
Palom et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: